Aarti Pharmalabs Ltd.
NSE: AARTIPHARM | BSE: 543748
₹642.35
₹9.10
(1.44%)
As on 01-Jun-2026IST
Market cap
₹5,824 Cr
Revenue (TTM)
₹1,819 Cr
P/E Ratio
33.3
P/B Ratio
2.7
Div. Yield
0.5 %
Quality Score
4/10
Growth Score
6/10
Valuation Score
5/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹187 Cr
-
ROE
14.5 %
-
ROCE
17.6 %
-
Industry P/E
45.61
-
EV/EBITDA
17.2
-
Debt to Equity
0.1
-
Book Value
₹234.4
-
EPS
₹20.8
-
Face value
5
-
Shares outstanding
90,657,751
6 Years Aggregate
CFO
₹754.31 Cr
EBITDA
₹1,397.71 Cr
Net Profit
₹805.03 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aarti Pharmalabs
| -14.6 | -13.2 | -11.2 | -29.5 | 20.3 | -- | -- |
|
BSE Healthcare
| 7.0 | 4.1 | 5.8 | 9.1 | 25.2 | 13.6 | 11.8 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Aarti Pharmalabs
| 7.6 | 35.8 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aarti Pharmalabs
|
642.4 | 5,824.3 | 1,819.4 | 178.5 | 15.4 | 9.1 | 33.3 | 2.7 |
| 3,018.9 | 24,691.1 | 1,339.4 | 356.4 | 33.2 | 23.2 | 69.3 | 14.9 | |
| 429.4 | 16,427.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91.7 | 4.2 | |
| 779.0 | 19,314.5 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.5 | 3.8 | |
| 933.3 | 16,714.5 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.8 | 1.8 | |
| 1,837.8 | 21,049.5 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.6 | |
| 170.9 | 22,710.2 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 1,171.1 | 19,301.0 | 1,284.3 | 134.4 | -- | 30.7 | 78.2 | 15.8 | |
| 448.0 | 18,088.4 | 3,738.7 | 316.7 | 12.5 | 7.5 | 57.1 | 3.7 | |
| 2,152.9 | 34,965.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 164.2 | 7.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Aarti Pharmalabs
Aarti Pharmalabs Limited, together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active... pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system (CNS) agents, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acidic and allied products comprising sulphuric acid, sulphur trioxide, oleum, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai, India. Read more
-
Incorporated
2019
-
Chairman
Rashesh C Gogri
-
Managing Director
Narendra J Salvi
-
Headquarters
Vapi, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsCorporate Action-Board to consider Dividend
25-May-2026No News & Announcements are available.
FAQs for Aarti Pharmalabs
What is the current share price of Aarti Pharmalabs Ltd Today?
The share price of Aarti Pharmalabs Ltd is ₹642.35 (NSE) and ₹642.45 (BSE) as of 01-Jun-2026 IST. Aarti Pharmalabs Ltd has given a return of 20.29% in the last 3 years.
What is the current PB & PE ratio of Aarti Pharmalabs Ltd?
The P/E ratio of Aarti Pharmalabs Ltd is 33.34 times as on 01-Jun-2026, a 27 discount to its peers’ median range of 45.61 times.
The P/B ratio of Aarti Pharmalabs Ltd is 2.74 times as on 01-Jun-2026, a 28 discount to its peers’ median range of 3.80 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
24.91
|
3.41
|
|
2024
|
18.18
|
2.24
|
|
2023
|
12.86
|
1.60
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Aarti Pharmalabs Ltd?
The 52-week high and low of Aarti Pharmalabs Ltd are Rs 971.00 and Rs 585.00 as of 02-Jun-2026.
What is the market cap of Aarti Pharmalabs Ltd?
Aarti Pharmalabs Ltd has a market capitalisation of ₹ 5,824 Cr as on 01-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Aarti Pharmalabs Ltd?
Before investing in Aarti Pharmalabs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.